Company: LIMN
Filing Date: 2025-06-24
Form Type: S-1
Source: 0001410578-25-001432
Chunk: 299

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-24
Form: S-1
Chunk 299
---
 ​                                                                                                          | ​ |                                  |          ​ | ​ |   |          ​ |
| Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption | ​ |                                  |  7,191,610 | ​ | ​ |  3,040,753 |
| Basic and diluted net loss per share, Class A common stock subject to possible redemption                  | ​ | $                                |      -0.40 | ​ | $ |      -0.15 |
| Basic and diluted weighted average shares outstanding, Class B common stock                                | ​ |                                  |          — | ​ |   |  4,971,781 |
| Basic and diluted net loss per share, Class B common stock                                                 | ​ | $                                |          — | ​ | $ |      -0.15 |

The accompanying notes are an integral part of these financial statements.

F-79

IRIS ACQUISITION CORP STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT FOR THE YEARS ENDED DECEMBER 31, 2024 AND 2023

| ​                                                                     
 ​                                                                     
 ​                                                                     
 ​                                                                     | ​ 
 ​ 
 ​ |            ​ 
      Class A 
 Common Stock 
       Shares | ​ | ​      
 Amount |   ​ | ​ 
 ​ 
 ​ |            ​ 
      Class B 
 Common Stock 
       Shares | ​ | ​      
 Amount |    ​ | ​ 
 ​ 
 ​ | ​            
 Extension    
 deposits due 
 from Sponsor |        ​ | ​ 
 ​ 
 ​ | ​          
 Additional 
 Paid-in    
 Capital    |        ​ | ​ 
 ​ 
 ​ | ​           
 ​           
 Accumulated 
 Deficit     |           ​ 
           ​ | ​ 
 ​ 
 ​ | ​             
 Total         
 Stockholders’ 
 Deficit       |           ​ |
|:----------------------------------------------------------------------|:--|-------------:|:--|:-------|----:|:--|-------------:|:--|:-------|-----:|:--|:-------------|---------:|:--|:-----------|---------:|:--|:------------|------------:|:--|:--------------|------------:|
| Balance as of January 1, 2022                                         | ​ |            — | ​ | $      |   — | ​ |    6,900,000 | ​ | $      |  690 | ​ | $            |        — | ​ | $          |  140,000 | ​ | $